🔍

ION Exchange (India) Limited (IONEXCHANG)

₹377.50 -0.05% last close, 16 Oct

📊 NSE: IONEXCHANG 🏢 Engineering - Turnkey Services 📢 Latest filing: 11 Sep 2026 📝 Analysis written: 14 Dec 2025

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, ION Exchange's revenue was ₹700 Cr (+20.1% year on year, -18.8% on the previous quarter), and net profit ₹3.1 Cr (-93.7% year on year); the operating margin was 4.5%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹700	+20.1%	-18.8%
Operating profit	₹31.7	-49.2%	+58.7%
Net profit	₹3.1	-93.7%	-87.2%
EPS (₹)	0.35	-91.6%	-79.0%
Operating margin	4.5%	—	—

Full quarterly financials → Results calendar →

IONEXCHANG delivery percentage

NSE end-of-day data for Fri, 16 Oct 2026

On Fri, 16 Oct 2026, 52.24% of the IONEXCHANG shares traded on NSE were taken to delivery, against the stock's own 20-session average of 45.82%. That is close to its usual level. Volume was 0.3 times its average, well below normal.

52.24%Delivery, 16 Oct

45.82%Own 20-session average

0.3×Volume vs its average

₹377.50NSE close · -0.05%

Delivery in the last 5 sessions: 51.6% · 39.9% · 46.1% · 55.3% · 52.2%

Delivery across the market →

A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed

📢 Recent Corporate Announcements

Ion Exchange Shareholders Approve All 4 AGM Resolutions Including FY26 Dividend

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 11 Sep 2026, 06:25 PM

Ion Exchange (India) Limited declared the voting results and Scrutinizer's Report for its 62nd Annual General Meeting held on September 11, 2026. All four ordinary resolutions—adoption of FY26 financial statements, declaration of dividend on equity shares, re-appointment of Director Dinesh Sharma, and ratification of cost auditors' remuneration—were passed with overwhelming requisite majorities exceeding 99%. A total of 15,100,879 votes by relatives of Dinesh Sharma were treated as invalid for Resolution 3 pursuant to compliance norms.

All 4 ordinary resolutions approved with >99% votes in favour
Resolution 1 (FY26 Financials) and Resolution 2 (Dividend) passed with 99.99% favour (70,598,208 votes)
Resolution 3 (Director Re-appointment) approved with 99.10% valid votes in favour
15,100,879 votes held by relatives of Dinesh Sharma excluded as invalid for Resolution 3
AGM attended by 149 shareholders via video conferencing (6 promoter group, 143 public)

💡 Track subsequent corporate disclosures for the exact dividend payment timeline and monitor upcoming Q2 FY27 earnings for operational performance.

Ion Exchange Concludes 62nd AGM; Approves FY26 Accounts and Dividend

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 11 Sep 2026, 06:17 PM

Ion Exchange (India) Limited concluded its 62nd Annual General Meeting on September 11, 2026, conducted via video conferencing. Key ordinary business items were approved with the requisite majority, including the adoption of FY26 standalone and consolidated financial statements, declaration of dividend on equity shares, and the re-appointment of retiring director Mr. Dinesh Sharma. Additionally, the remuneration of Cost Auditors was ratified as special business. The meeting registered participation from 80 authorised representatives representing 2,86,19,100 equity shares.

Concluded 62nd Annual General Meeting on September 11, 2026, held from 11:00 AM to 12:14 PM
Authorised representation received under Section 113 from 80 Members holding 2,86,19,100 Equity Shares
Remote e-voting was active from September 7, 2026 (9:00 AM) to September 10, 2026 (5:00 PM)
Approved adoption of FY26 financials, equity dividend declaration, and director re-appointment by requisite majority

💡 Track the upcoming final scrutinizer's report for formal voting percentages and look out for Q2 FY27 earnings to monitor engineering margin trends.

ION Exchange Sets Aug 31, 2026 Record Date for Dividend; 62nd AGM on Sept 11

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 18 Aug 2026, 05:35 PM

ION Exchange (India) Limited has dispatched a notice to shareholders regarding its 62nd Annual General Meeting scheduled for September 11, 2026, via video conferencing. The company has fixed August 31, 2026, as the record date for determining eligibility for dividend. Remote e-voting will take place from September 7 to September 10, 2026, based on the cut-off date of September 4, 2026. Approved dividends will be disbursed within 30 days following the AGM.

62nd AGM scheduled for Friday, September 11, 2026, at 11:00 AM IST via video conference
Record date for dividend eligibility set as Monday, August 31, 2026
Cut-off date for e-voting is Friday, September 4, 2026, with voting window from Sept 7 to Sept 10, 2026
Dividend payment timeline fixed within 30 days from the date of AGM approval

💡 Shareholders seeking dividend eligibility should ensure shareholding before August 31, 2026, and submit TDS exemption forms by September 7, 2026.

ION Exchange Schedules 62nd AGM on Sep 11, 2026; Sets Dividend Record Date as Aug 31

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 18 Aug 2026, 05:06 PM

ION Exchange (India) Limited has issued the notice for its 62nd Annual General Meeting (AGM) scheduled for September 11, 2026, via Video Conferencing. Key agenda items include the adoption of FY26 financial statements, declaration of equity dividend, and the re-appointment of Vice-Chairman Mr. Dinesh Sharma (holding 57,12,710 shares) retiring by rotation. The record date for dividend eligibility is August 31, 2026, with dividend payout planned within 30 days of approval. Shareholders will also vote on ratifying ₹4.75 lakh remuneration for cost auditors for FY27.

62nd AGM scheduled for Friday, September 11, 2026, at 11:00 AM IST via Video Conference.
Dividend record date fixed as August 31, 2026, with payment to be made within 30 days of AGM declaration.
Proposed ratification of ₹4,75,000 remuneration for Cost Auditors (M/s. R. Nanabhoy & Co.) for FY27.
Re-appointment of Director Mr. Dinesh Sharma, who holds 57,12,710 shares and is liable to retire by rotation.
83,526 shares transferred to the IEPF Authority during FY26 in compliance with statutory rules.

💡 Eligible shareholders seeking dividend entitlement must hold shares as of August 31, 2026, and submit tax exemption forms (15G/15H) by September 7, 2026.

Ion Exchange Outlines Segment Reclassification, 5x Roha Resin Capacity Expansion in Call

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 17 Aug 2026, 10:22 PM

Ion Exchange (India) Limited submitted the transcript of its analyst call held on August 10, 2026, which covered the strategic rationale for reclassifying its reporting segments and operational updates. Management highlighted the commissioning of its Roha plant, expanding conventional resin manufacturing capacity by 5x to target a 4x increase in global market share into double-digit percentages. Furthermore, the company is undertaking a 6x capacity expansion in FDA-approved pharma resins at Ankleshwar. International markets currently account for approximately 30% of total revenues across operations in 50+ countries.

Commissioned Roha plant increases conventional resin manufacturing capacity by 5x using non-solvent technology
Pharma resin capacity at the FDA-approved Ankleshwar plant is expanding by 6x
Company aims to increase its global ion exchange resin market share by 4x into double-digit levels
International markets across 50+ countries currently contribute 30% of total company revenue

💡 Track the ramp-up timeline and margin profile of the Roha resin plant and Ankleshwar pharma expansion in upcoming quarterly earnings.

ION Exchange Releases Q1 FY27 Earnings Call Recording

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 10 Aug 2026, 06:52 PM

ION Exchange has released the audio recording of its earnings conference call for the first quarter of FY 2026-27, held on August 10, 2026. The call discussed the company's operational and financial performance for the period ending June 30, 2026. This disclosure is critical for investors to understand management's perspective on the recent margin compression, where Operating Profit Margins (OPM) fell to 7.2% in FY26 from 10.7% in FY25. The recording provides insights into the progress of the Roha resin plant and the integration of the Mapril acquisition in Europe.

Earnings conference call conducted on August 10, 2026, for the Q1 FY27 period.
Company reported TTM revenue of Rs 2,915 Cr with a current market capitalization of Rs 4,732 Cr.
Operating Profit Margin (OPM) for FY26 was 7.2%, down from 11.57% in FY24.
Management is managing a significant legacy order of Rs 1,156 Cr from the Uttar Pradesh government.
Debt-to-Equity ratio remains low at 0.29, providing headroom for the ongoing Roha greenfield expansion.

💡 Investors should listen to the recording for updates on the commissioning timeline of the Roha resin plant and any commentary regarding the resolution of funding issues for the Uttar Pradesh EPC contracts.

ION Exchange Restructures Segments; Plans 2X Resin Capacity Expansion at Roha

🟡 NEUTRAL ⭐ 6/10

EXPANSION 📅 10 Aug 2026, 06:46 PM

ION Exchange has restructured its reporting into five granular segments to improve transparency, revealing that Specialty Chemicals is the primary profit driver with Rs 177 Cr EBIT in FY26. The company is executing a 2X capacity expansion in Industrial Resins at Roha, featuring India's first non-solvent resin facility. While Treatment Solutions revenue grew at a 23% CAGR to Rs 1,122 Cr, its EBIT has declined significantly from Rs 60 Cr in FY22 to Rs 27 Cr in FY26. International operations now contribute 30% of total revenue, supported by 14 global manufacturing and assembly centers.

Restructured reporting into 5 segments: Treatment Solutions, Industrial Products, Lifecycle Services, Specialty Chemicals, and Consumer Products.
Specialty Chemicals segment generated Rs 177 Cr EBIT on Rs 868 Cr revenue in FY26, maintaining a 10% EBIT CAGR.
Treatment Solutions segment revenue reached Rs 1,122 Cr in FY26, but EBIT margins have compressed to a -18% CAGR over four years.
Doubling (2X) capacity for Industrial Resins at Roha to target a global market share increase from 2% to 5%.
Lifecycle Services segment showed strong growth with a 21% EBIT CAGR, reaching Rs 38 Cr in FY26.

💡 Monitor the margin recovery in the Treatment Solutions segment and the execution timeline of the Roha resin plant expansion, which is critical for global market share gains.

ION Exchange Q1 FY27: Revenue up 20% to ₹700 Cr, but PAT drops 93% on margin pressure

🔴 NEGATIVE ⭐ 7/10

EARNINGS 📅 10 Aug 2026, 01:15 PM

ION Exchange reported a 20.1% YoY increase in consolidated revenue to ₹700.5 Cr for Q1 FY27. However, profitability was severely impacted, with consolidated PAT dropping 93.6% to ₹3.1 Cr compared to ₹48.4 Cr in the same quarter last year. The decline was driven by a 622 bps contraction in EBITDA margins to 4.54%, primarily due to legacy project costs in the Treatment Solutions segment and higher depreciation from the Roha facility. Despite the earnings miss, the company maintains a healthy order book of ₹2,473 Cr and a massive bid pipeline of ₹9,777 Cr.

Consolidated revenue grew 20.1% YoY to ₹700.5 Cr, though it declined 18.9% sequentially.
Consolidated PAT fell sharply to ₹3.1 Cr from ₹48.4 Cr YoY, a 93.6% decline.
Operating EBITDA margins contracted significantly to 4.54% from 10.75% in Q1 FY26.
Total outstanding order book stands at ₹2,473 Cr, excluding a recent $52.83 Mn (approx. ₹440 Cr) Hyundai order.
Bid pipeline remains robust at ₹9,777 Cr, providing visibility for future order inflows.

💡 Investors should monitor the timeline for liquidating low-margin 'legacy projects' in the Treatment Solutions segment, which is currently dragging down overall profitability. The ramp-up of the Roha resin plant and the execution of the new $52.83 Mn Hyundai order are key triggers to watch for margin recovery.

ION Exchange Targets 10% Global Resin Market Share; Plans 5X Capacity Expansion at Roha

🟡 NEUTRAL ⭐ 6/10

EXPANSION 📅 10 Aug 2026, 12:42 PM

ION Exchange is aggressively scaling its resin business, targeting a global market share increase from 2.5% to 10% through a 5X capacity expansion at its Roha facility. Despite TTM revenue growth to Rs 2,915 Cr, FY26 EBIT margins faced pressure, with the Specialty Chemicals segment EBIT dropping from Rs 207 Cr to Rs 177 Cr year-on-year. The company is reorganizing into five new reporting segments to improve operational focus. International operations remain a key pillar, contributing 30% of total revenue across 50+ countries.

Targeting a 4x increase in global resin market share from current 2.5% to 10%
Executing a 5X capacity expansion for Industrial Resins at the Roha facility
Executing a 4X capacity expansion for Pharma Resins at the Ankleshwar facility
Consumer Products segment revenue grew 31% to Rs 343 Cr in FY26, though it remains EBIT negative at -Rs 10 Cr
Specialty Chemicals segment revenue reached Rs 868 Cr in FY26, contributing ~30% of total revenue

💡 Monitor the commissioning and ramp-up timeline of the Roha greenfield resin plant, as this is the primary driver for the 10% global market share target. Investors should also watch for margin recovery in the Treatment Solutions segment, where EBIT fell from Rs 30 Cr to Rs 27 Cr despite revenue growth.

Aug 10: ION Exchange to Hold Special Call on Segment Reclassification and Q1 Earnings

🟡 NEUTRAL ⭐ 4/10

ROUTINE 📅 05 Aug 2026, 10:34 PM

ION Exchange has scheduled two investor conference calls for August 10, 2026. The first session at 2:00 PM IST will focus on a 'Reclassification of Reporting Segments,' a move that will change how the company presents its financial performance across its business verticals. This will be followed by the Q1 FY27 earnings call at 3:00 PM IST. Investors should note that TTM operating margins have recently compressed to 7.2% compared to 10.7% in FY25, making the new segment clarity crucial for performance analysis.

Special Call on Reclassification of Reporting Segments scheduled for August 10, 2026, at 2:00 PM IST
Q1 FY27 Earnings Conference Call scheduled for August 10, 2026, at 3:00 PM IST
Management representation includes the Vice Chairman, MD & CEO, and Group CFO
Company reported TTM Revenue of ₹2,915 Cr and TTM PAT of ₹143 Cr as of the latest available data
Current Market Cap stands at ₹5,101 Cr with a P/E ratio of 35.7

💡 Listen to the 2:00 PM call to understand the rationale behind segment reclassification and how it will impact historical year-on-year comparisons of the Engineering and Chemical divisions.

ION Exchange Q1 PAT Drops 75% YoY to ₹11.4 Cr Despite 23% Revenue Growth

🔴 NEGATIVE ⭐ 7/10

EARNINGS 📅 05 Aug 2026, 08:16 PM

ION Exchange reported a 22.7% YoY increase in standalone revenue to ₹635.56 Cr for Q1 FY27, but standalone net profit plummeted 75.7% to ₹11.40 Cr. The profitability decline was driven by a 41.2% surge in 'Other Expenses' and a nearly 5x spike in finance costs to ₹8.21 Cr. Consolidated profit before tax saw an even sharper decline of 89% YoY to ₹6.99 Cr. Strategically, the company has reorganized its Engineering segment into three new units—Treatment Solutions, Industrial Products, and Lifecycle Services—to pivot toward technology-led solutions.

Standalone Revenue grew 22.7% YoY to ₹635.56 Cr from ₹517.83 Cr
Standalone Net Profit fell 75.7% YoY to ₹11.40 Cr from ₹46.88 Cr
Finance costs increased by 394.6% YoY to ₹8.21 Cr from ₹1.66 Cr
Other Expenses rose 41.2% YoY to ₹103.58 Cr
Consolidated Profit Before Tax fell 89.3% YoY to ₹6.99 Cr from ₹65.46 Cr

💡 Investors should monitor the margin recovery in the newly formed 'Lifecycle Services' and 'Specialty Chemicals' segments and watch for the commissioning timeline of the Roha resin plant to offset current cost pressures.

ION Exchange Submits Routine SEBI DP Compliance Certificate for Q1 Ended June 30, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 14 Jul 2026, 02:52 PM

ION Exchange (India) Limited has filed its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by the Registrar and Transfer Agent MUFG Intime India Private Limited, confirms that securities received for dematerialization during the quarter ended June 30, 2026, have been processed. This is a standard administrative filing required for all listed entities to ensure the integrity of shareholding records. It has no impact on the company's financial health or operational performance.

Compliance certificate submitted for the first quarter ended June 30, 2026
Certificate issued by Registrar and Transfer Agent, MUFG Intime India Private Limited
Confirms adherence to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
The filing is a routine procedural requirement for listed companies in India

💡 No action is required as this is a routine regulatory filing. Investors should monitor upcoming quarterly financial results for updates on the Roha resin plant commissioning and European expansion.

Rs 503 Cr International Order Win from Hyundai Engineering for Middle East Project

🟢 POSITIVE ⭐ 8/10

OTHER 📅 10 Jul 2026, 12:22 PM

ION Exchange (India) Limited has secured a significant international contract worth approximately Rs 503 crore (USD 52.83 million) from Hyundai Engineering & Construction Co. Ltd. The contract involves the supply of filtration units for a project in the Middle East, with an execution timeline of 18 months. This order represents approximately 17.3% of the company's TTM revenue of Rs 2,915 crore, providing strong revenue visibility for the next six quarters. The win aligns with the company's strategy to consolidate its market position in the Gulf region.

Awarded an international contract worth USD 52.83 million (approx. INR 503 crore) by Hyundai Engineering & Construction Co. Ltd.
The project involves the supply of filtration units specifically for the Middle East market.
Execution is scheduled over a period of 18 months, providing steady revenue flow through late 2027.
The order value constitutes approximately 17.3% of the company's total TTM revenue of Rs 2,915 crore.

💡 Investors should monitor the company's quarterly execution progress and operating margins, as engineering segment EBIT margins have recently faced pressure at 4.8%.

ION Exchange to Close Trading Window from July 1, 2026, for Q1 Results

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 26 Jun 2026, 11:13 AM

ION Exchange (India) Limited has announced the closure of its trading window starting July 1, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations. This closure is ahead of the declaration of the company's unaudited financial results for the first quarter ending June 30, 2026. The restriction applies to all designated persons and their immediate relatives. The window will remain closed until 48 hours after the financial results are made public.

Trading window closure effective from Wednesday, July 1, 2026.
Closure is related to the first quarter (Q1) results ending June 30, 2026.
Restriction extends until 48 hours after the official result declaration.
Complies with SEBI (Prohibition of Insider Trading) Regulations, 2015.

💡 This is a routine regulatory filing with no impact on company fundamentals. Investors should wait for the upcoming Q1 earnings report to assess the company's financial performance.

Ion Exchange Q4 FY26: Revenue Up 3% to ₹863 Cr; FY26 EBITDA Drops 29% on Margin Pressure

🟡 NEUTRAL ⭐ 8/10

EARNINGS 📅 05 Jun 2026, 05:23 PM

Ion Exchange (India) Limited reported a consolidated revenue of INR 8,633 million for Q4 FY26, a 3% YoY increase, though full-year EBITDA fell 29% to INR 2,102 million due to rising input costs and geopolitical disruptions. The engineering order book remains strong at INR 26,433 million, bolstered by a major OMR 73.46 million contract in Oman and a USD 18.1 million project in Malawi. Management is focusing on high-tech membrane segments through a new partnership with MANN+HUMMEL and expects the newly commissioned Roha facility to reach 25% utilization in the coming year.

FY26 consolidated revenue reached INR 29,148 million (+7% YoY), but EBITDA margins contracted to 7.21% from the previous year.
Engineering order book stands at a healthy INR 26,433 million as of March 31, 2026, providing strong revenue visibility.
The company entered a strategic technology transfer and manufacturing collaboration with MANN+HUMMEL for ultra-filtration membranes.
West Asia crisis impacted Q4 margins due to deferred export shipments worth approximately INR 600 million and higher raw material costs.
Consumer Product Division showed strong growth with revenue increasing 34% YoY to INR 1,047 million in Q4.

💡 Investors should focus on the company's ability to pass on increased input costs and the ramp-up of the Roha facility to improve margins. While the order book is robust, short-term profitability remains sensitive to geopolitical stability in West Asia and logistics costs.

View All IONEXCHANG Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

The Engineering segment grew 16% YoY in Q2 FY26 to INR 456.2 Cr. In FY23, the Engineering segment saw a 33% YoY increase, while the Chemical segment grew 11% YoY. Overall consolidated revenue grew 9% YoY in Q2 FY26 to INR 642.9 Cr.

Geographic Revenue Split

Not disclosed in available documents, though the company highlights growth in the Gulf, Emerging Markets, and North Africa (desalination projects), while Europe faced muted demand.

Profitability Margins

Consolidated PAT margin for Q2 FY26 was 7.47%, a slight decline from the 9.8% recorded in FY23. Engineering segment EBIT margins hit an all-time low of 4.8% in Q2 FY26 due to project mix and high infrastructure investments.

EBITDA Margin

EBITDA margin stood at 9.95% in Q2 FY26, representing a 1% YoY decline in absolute EBITDA to INR 131 Cr. Operating margins for the full fiscal 2024 moderated to 11.7% from 13.3% in FY23.

Capital Expenditure

The company is executing a capital expenditure plan of over INR 250 Cr between FY23 and FY25, primarily focused on the greenfield resin manufacturing facility in Roha, Maharashtra.

Credit Rating & Borrowing

CRISIL A+/Stable for long-term and CRISIL A1 for short-term. Interest coverage ratio was strong at 24.8 times in FY23, with debt expected to remain below INR 100 Cr despite high capex.

⚙️ Operational Drivers

Raw Materials

Key raw materials include resins, membranes, and steel for engineering projects. Specific percentage of total cost for each is not disclosed.

Import Sources

Sourced from India (Roha plant) and Europe (leveraging the Mapril acquisition). The company is also licensing membrane technology from Mann+Hummel.

Key Suppliers

Mann+Hummel (technology partner for membranes); other specific raw material suppliers are not disclosed.

Capacity Expansion

Current capacity not specified in MT; however, the company is commissioning a greenfield resin plant in Roha and has recently commissioned a 40 MLD desalination plant in North Africa with 60 MLD and 40 MLD plants in progress.

Raw Material Costs

Raw material costs are impacted by supply chain surges; the company managed a surge in costs driven by Suez Canal constraints which impacted cargo movement.

Manufacturing Efficiency

The company is leveraging its 'low-cost country presence' in India to manufacture membranes for global consumption under the Mann+Hummel partnership.

Logistics & Distribution

Impacted by Suez Canal constraints; the company is leveraging local presence in Europe through Mapril to optimize regional distribution.

📈 Strategic Growth

Expected Growth Rate

12-15%

Growth Strategy

Growth will be driven by the commissioning of the Roha resin plant, expansion into the European market via the Mapril acquisition, and a technology licensing agreement with Mann+Hummel for membrane manufacturing. The company is also targeting high-growth sectors like solar and pharmaceuticals for ultra-pure water projects.

Products & Services

Ion exchange resins, water softeners, desalination plants (40-60 MLD), ultra-pure water systems for solar/pharma, and long-term Operation & Maintenance (O&M) services.

Brand Portfolio

Ion Exchange, Zero-B (implied via consumer segment leadership in softeners).

New Products/Services

New range of membranes manufactured in India via Mann+Hummel technology; expected to contribute to global consumption and expand market share in the water treatment segment.

Market Expansion

Targeting the European continent using Mapril as a springboard and consolidating positions in the Gulf and North Africa.

Market Share & Ranking

Maintains a leadership position in the domestic water softener segment.

Strategic Alliances

Technology licensing agreement with Mann+Hummel for membrane manufacturing; acquisition of Mapril in Europe.

🌍 External Factors

Industry Trends

Increasing demand for environmental infrastructure and desalination; shift toward ultra-pure water requirements in the solar and pharmaceutical manufacturing sectors.

Competitive Landscape

Operates in a highly competitive engineering segment; competes with global and domestic water treatment players.

Competitive Moat

Durable advantage through a diverse product mix and market leadership in water treatment. The chemical segment (resins) provides a high-margin (20%+) cushion against the cyclical engineering business.

Macro Economic Sensitivity

High sensitivity to industrial capex cycles; any slowdown in the Indian economy or end-user industries (Power, Steel, Fertilizers) adversely affects revenue.

Consumer Behavior

Steady demand for water softeners and home water solutions; segment recorded healthy volume growth despite a small quarterly loss of INR 2.7 Cr.

Geopolitical Risks

Suez Canal route constraints for cargo movement and potential impacts from global tariff wars (though US/Euro business currently remains unaffected).

⚖️ Regulatory & Governance

Industry Regulations

Operations are subject to pollution norms and manufacturing standards; the Roha project required specific licenses and approvals which were previously delayed by the pandemic.